MAPT and Alzheimer disease: The AD-like tau deposition that has been understood as exhibiting a systematic staging (i.e. Braak stages)2 over the disease course, while the neurodegeneration (neuronal loss, i.e. atrophy) is not considered pathognomonic but associates closely with tau pathology3–5.